Recent Finacing
Recent Raise
Sapreme Technologies develops an endosomal-escape platform and compounds (e.g., SPT001) to enhance intracellular delivery of macromolecule therapeutics, supporting an internal oncology pipeline and partnering across biologic modalities.
